68-1

61/98

tomography with pathological scar in small lung adenocarcinomas. Jpn J Clin Oncol, 2007; 37: 913-7. 27) Ichikawa T, Hattori A, Suzuki K, et al: Clinicopatholog-ical characteristics of lung cancer mimicking orga-nizing pneumonia on computed tomography-a novel radiological entity of pulmonary malignancy. Jpn J Clin Oncol, 2016; 46: 681-6. 28) Aherne EA, Plodkowski AJ, Montecalvo J, et al: What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology? Lung Cancer, 2018; 118: 83-89. 29) Nelson DB, Godoy MCB, Benveniste MF, et al: Clini-coradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass Components. Ann Thorac Surg, 2018; 106: 235-241. 30) Aokage K, Miyoshi T, Ishii G, et al: Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer. J Thorac Oncol, 2018; 13: 533-542. 31) Berry MF, Gao R, Kunder CA, et al: Presence of Even a Small Ground-Glass Component in Lung Adenocarci-noma Predicts Better Survival. Clin Lung Cancer, 2017. 32) Ye T, Deng L, Wang S, et al: Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype. J Thorac Oncol, 2019. 33) Ye T, Deng L, Xiang J, et al: Predictors of Pathologic Tumor Invasion and Prognosis for Ground Glass Opacity Featured Lung Adenocarcinoma. Ann Thorac Surg, 2018; 106: 1682-1690. 34) Yip R, Li K, Liu L, et al: Controversies on lung cancers manifesting as part-solid nodules. Eur Radiol, 2018; 28: 747-759. 35) Fu F, Zhang Y, Wen Z, et al: Distinct Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions. J Thorac Oncol, 2019; 14: 2133-2142. 36) Hattori A, Takamochi K, Oh S, et al: New revisions and current issues in the eighth edition of the TNM classi-fication for non-small cell lung cancer. Jpn J Clin Oncol, 2019; 49: 3-11. 37) Ginsberg RJ, Rubinstein LV: Randomized trial of lobec-tomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60: 615-22; discussion 622-3, 1995. 38) Suzuki K, Watanabe SI, Wakabayashi M, et al: A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer. J Thorac Cardiovasc Surg, 2020. 39) Nakamura K, Saji H, Nakajima R, et al: A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol, 2011; 40: 271-4. 40) Hattori A, Matsunaga T, Takamochi K, et al: Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma. J Thorac Cardiovasc Surg, 2017; 154: 1100-1108. 41) Hattori A, Matsunaga T, Takamochi K, et al: Locore-gional recurrence after segmentectomy for clinical- T1aN0M0 radiologically solid non-small-cell lung carcinoma. Eur J Cardiothorac Surg, 2017; 51: 518-525.59